Remove privacy-notice terms
article thumbnail

He Slimed Me: FTC Hits GoodRx Over Unauthorized Use of Consumer Data

The FDA Law Blog

The Federal Trade Commission (FTC) and its partners at DOJ’s Consumer Protection Branch recently file a civil complaint against GoodRx for data privacy breaches. Perhaps these terms are severe to GoodRx, but the civil penalty was noticeably small compared to other FTC data privacy cases. The penalty of $1.5

FDA 105
article thumbnail

Resolving challenges with product recovery in biopharma manufacturing

Pharmaceutical Technology

As you make the bioreactor more productive, you create higher impurity levels both in terms of soluble and insoluble impurities. However, both these options can result in higher impurity levels, which places additional burden on the clarification and the rest of the downstream process. “As Download to learn more.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Ep. 002 – John Mack Podcast Transcript

Pharma Marketing Network

So one thing that we’ve noticed since we’ve relaunched is, SEO seems to like it, it’s coming back in terms of traffic, and we think that’s going to continue to grow. I think that’ll be a big piece of what we do then, just overall, in terms of the industry suppliers that are out there.

article thumbnail

Overcoming challenges with scalability in biopharma manufacturing

Pharmaceutical Technology

This problem is particularly evident for centrifugation, where the performance, in terms of particle removal and cell shear, in small batch centrifuges, is very different from the continuous centrifuges used at manufacturing scale,” explains Dr Hani El-Sabbahy, Advanced Application Engineering Specialist from 3M. Download to learn more.

article thumbnail

Streamlining Postapproval Submissions Using ICH Q12 & SCDM

ISPE

In July 2021, Health Canada (HC) released an updated draft guidance for its Post-Notice of Compliance (NOC) Changes and solicited public comments. However, the long-term expectation is that the use of ICH Q12 and ECs will decrease the need for postapproval filings and regulatory agency interactions. Hoath, C., 16 Health Canada.

article thumbnail

A Proposal for a Comprehensive Quality Overall Summary

ISPE

Submission of Chemistry, Manufacturing, and Controls Information in a New Drug Application Under the New Pharmaceutical Quality Assessment System; Notice of Pilot Program.” For more information or to unsubscribe, review our Privacy Policy or contact us at ask@ispe.org. 1 a b c 4 Shuren, J. 2005N–0262) Federal Register (2005).

article thumbnail

A Proposal for a Comprehensive Quality Overall Summary

ISPE

Submission of Chemistry, Manufacturing, and Controls Information in a New Drug Application Under the New Pharmaceutical Quality Assessment System; Notice of Pilot Program.” For more information or to unsubscribe, review our Privacy Policy or contact us at ask@ispe.org. 1 a b c 4 Shuren, J. 2005N–0262) Federal Register (2005).